PharmaEssentia (FRA:8Z1) E10: €-0.01 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8Z1 PharmaEssentia Corp FRA:8Z1
75 GF Score
Price €13.96
GF Value €10.75
! 4 Warning Signs
View Full Analysis

What is PharmaEssentia E10?

PharmaEssentia FRA:8Z1 75 E10 is €-0.01 as of Jun. 2026. GuruFocus rates FRA:8Z1 with a GF Score™ of 75/100 and a GF Value™ of €10.75. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PharmaEssentia's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.152. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.01 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-26), PharmaEssentia's current stock price is €13.96396. PharmaEssentia's E10 for the quarter that ended in Jun. 2026 was €-0.01. PharmaEssentia's Shiller PE Ratio of today is .


PharmaEssentia  (FRA:8Z1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PharmaEssentia E10 Related Terms


PharmaEssentia E10 Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia E10 Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PharmaEssentia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.04 -0.01

FRA:8Z1 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Shiller PE Ratio falls into.


FRA:8Z1
75GF Score
PharmaEssentia Corp FRA:8Z1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaEssentia's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.152/333.9520*333.9520
=0.152

Current CPI (Jun. 2026) = 333.9520.

PharmaEssentia Quarterly Data

per share eps CPI Adj_EPS
201609 -0.024 241.428 -0.033
201612 -0.026 241.432 -0.036
201703 -0.025 243.801 -0.034
201706 -0.022 244.955 -0.030
201709 -0.020 246.819 -0.027
201712 -0.025 246.524 -0.034
201803 -0.023 249.554 -0.031
201806 -0.021 251.989 -0.028
201809 -0.024 252.439 -0.032
201812 -0.037 251.233 -0.049
201903 -0.029 254.202 -0.038
201906 -0.021 256.143 -0.027
201909 -0.030 256.759 -0.039
201912 -0.010 256.974 -0.013
202003 -0.031 258.115 -0.040
202006 -0.022 257.797 -0.028
202009 -0.056 260.280 -0.072
202012 -0.077 260.474 -0.099
202103 -0.063 264.877 -0.079
202106 -0.050 271.696 -0.061
202109 -0.067 274.310 -0.082
202112 -0.088 278.802 -0.105
202203 -0.051 287.504 -0.059
202206 -0.025 296.311 -0.028
202209 -0.038 296.808 -0.043
202212 -0.012 296.797 -0.014
202303 -0.061 301.836 -0.067
202306 -0.015 305.109 -0.016
202309 0.016 307.789 0.017
202312 0.009 306.746 0.010
202403 0.023 312.332 0.025
202406 0.048 314.175 0.051
202409 0.050 315.301 0.053
202412 0.088 315.605 0.093
202503 0.086 319.799 0.090
202506 0.053 322.561 0.055
202509 0.100 324.800 0.103
202512 0.097 324.054 0.100
202603 0.141 330.213 0.143
202606 0.152 333.952 0.152

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.01 mean?
PharmaEssentia (FRA:8Z1) has a E10 of €-0.01 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's E10 too high?
PharmaEssentia's current E10 is €-0.01. Overall, PharmaEssentia has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's E10 compare to ZTS?
PharmaEssentia's E10 of €-0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current E10 is €-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (FRA:8Z1) has a current E10 of €-0.01. The stock's GF Value™ is €10.75, compared to a current price of €13.96 — trading 29.9% above its estimated fair value. The current E10 is €-0.01. PharmaEssentia's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For PharmaEssentia (FRA:8Z1), the current E10 is €-0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (FRA:8Z1) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of €13.96 is trading 29.9% above its estimated GF Value™ of €10.75.

Key valuation signals for FRA:8Z1:

  • E10: €-0.01
  • GF Value™: €10.75 vs. price of €13.96 (29.9% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the FRA:8Z1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Other Exchanges 6446:Taiwan
Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
75GF Score

Get the complete analysis for FRA:8Z1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.96
Price
€10.75
GF Value